Overview:
Moxifloxacin 0.5% w/v is a fourth-generation fluoroquinolone antibiotic with broad-spectrum antibacterial activity. It works by inhibiting bacterial DNA gyrase, thereby preventing bacterial replication and reducing symptoms like redness, irritation, and discharge. Studies have shown its efficacy in bacterial conjunctivitis with a 92% resolution rate (J Cataract Refract Surg, 2018).
- Class
- Dosage
- Indications
- Mechanism of action
Fluoroquinolone Antibiotic
1 drop 3 times daily
Contromax-M Tablet can be used in the treatment of the following conditions:
Bacterial conjunctivitis (including multidrug-resistant strains)
Corneal ulcers
Pre- and post-operative prophylaxis in ocular surgeries
Microbial keratitis
Blepharitis and blepharoconjunctivitis
Inhibits bacterial DNA gyrase and topoisomerase IV, preventing supercoiling and strand separation required for bacterial DNA replication and transcription, leading to bacterial cell death.
